Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361(23):2209-20.

Pitisuttithum P, Rerks-Ngarm S, Kaewkungwal J, Nitayaphan S, Khamboonruang C, Kunasol P, Suntharasamai P, Benenson MW, Kim JH. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand (Abstract). AIDS VACCINE 2009, Paris, France, October 19-22, 2009 p.170

Rerks-Ngarm S, Pitisuttithum P, Kunasol P, Kim J. Phase III trial of HIV prime-boost vaccine combination in Thailand: result of final analysis (Abstract). AIDS VACCINE 2009, Paris, France, October 19-22, 2009 p.20

Kim JH, Kamasuta C, Trichavaroj R, Kaewkungwal J, Chantakulkij S, Ratto-Kim S, Eamsila C, Sukwit S, Nitayaphan S, Pitisuttihum P, Michael NL, Chiu J, Rerks-Ngarm S, de Souza MS. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial (Abstract). AIDS VACCINE 2009, Paris, France, October 19-22, 2009 p.54

Kaewkungwal J, Pitisuttithum P, Nitayapan S, Khamboonruang C, Khamboonruang C,  Thongchareon P, Kunasol P, Benenson M, Kim J. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand (Abstract). AIDS VACCINE 2009, Paris, France, October 19-22, 2009 p.182

Songthap A, Pitisuttithum P, Kaewkungwal J, Fungladda W, Bussaratid V, Koonsaeng S. Knowledge, Attitude, and Acceptability of a Human Papillomavirus Vaccine among Healthcare Providers. Southeast Asian J Trop Med Public Health 2009; 40(5):1048-56.

Nicholson O, DiCandilo F, Kublin J, Sun X, Quirk E, Miller M, Gray G, Pape J, Robertson MN, Mehrotra DV, Self S, Turner K, Sanchez J, Pitisuttithum P,  Duerr A, Dubey S, Kierstead L, Casimiro D, Hammer SM. Safety and Immunogenicity of the MRKAd5 gag HIV-1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. AIDS Res Hum Retroviruses. 2011 May; 27(5): 557–567.

Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW; Protocol G Principal Investigators, Miiro G, Serwanga J, Pozniak A, McPhee D, Manigart O, Mwananyanda L, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Allen S, Kaminsky S, Zamb T, Moyle M, Koff WC, Poignard P, Burton DR. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target. Science. 2009 Oct 9;326(5950):285-9.

Areechokchai D, Bowonwatanuwong C, Phonrat B, Pitisuttithum P, Maek-A-Nantawat W. Pregnancy Outcomes Among HIV-Infected Women Undergoing Antiretroviral Therapy. Open AIDS J. 2009 Mar 3; 3:8-13.

Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 2009; 373(9679):1949-57.

Maek-a-nantawat W, Phonrat B, Dhitavat J, Naksrisook S, Muanaum R, Ngamdee V, Pitisuttithum P. Safety and Efficacy of CKBM-A01, A Chinese Herbal Medicine, Among Asymptomatic HIV Patients. Southeast Asian J Trop Med Public Health 2009; 40(3):494-501.

Phonrat B, Ruengkris  T, Naksrisook S, Intalapaporn K, Jirakorbchaipong P, Pitisuttithum P. Psychosocial Burden of Women with Abnormal Pap Smears. Southeast Asian J Trop Med Public Health 2009; 40(3):593-601.

Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee D, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC. Human Immunodeficiency Virus Type1 Elite Neutralizers: Individuals with Broad and  Potent Neutralizing Activity Identified by Using a High Throughput Neuralization Assay together with an Analytical Selection Algorithum. J Virol 2009; 83(14):7337-48

Suntharasamai P, Martin M, Vanichseni S, Griensven FV, Mock PA, Pitisuttithum P, Tappero JW, Sangkum U, Kitayaporn D, Gurwith M, Choopanya. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003. Addiction 2009; 104, 235-242

Home